Neoadjuvant Chemotherapy in Small Cell Urothelial Cancer Improves Pathologic Downstaging and Long-term Outcomes: Results from a Retrospective Study at the MD Anderson Cancer Center-Reference-Cited by-同舟云学术

Neoadjuvant Chemotherapy in Small Cell Urothelial Cancer Improves Pathologic Downstaging and Long-term Outcomes: Results from a Retrospective Study at the MD Anderson Cancer Center

Published:2013-08 Issue:2 Volume:64 Page:307-313
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Lynch Siobhan P.,Shen Yu,Kamat Ashish,Grossman H. Barton,Shah Jay B.,Millikan Randall E.,Dinney Colin P.,Siefker-Radtke Arlene

Publisher

Elsevier BV

Subject

Urology

Reference14 articles.

1. Radical cystectomy for primary neuroendocrine tumors of the bladder: the University of Southern California experience;Quek;J Urol,2005

2. Evidence supporting preoperative chemotherapy for small cell carcinoma of the bladder: a retrospective review of the M. D. Anderson cancer experience;Siefker-Radtke;J Urol,2004

3. Small cell carcinoma of the urinary bladder: a clinicopathologic analysis of 64 patients;Cheng;Cancer,2004

4. Primary small cell carcinoma of the bladder: a report of 25 cases;Holmäng;J Urol,1995

5. Small cell carcinoma of the urinary bladder. A clinicopathologic, morphometric, immunohistochemical, and ultrastructural study of 18 cases;Blomjous;Cancer,1989

Cited by 150 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Small Cell Bladder Cancer: Treatment Patterns for Local Disease and Associated Outcomes. A Retrospective Cohort Study;Clinical Genitourinary Cancer;2024-12

2. A 2-center review of histopathology of variants of upper urinary tract urothelial carcinoma and their impact on clinical outcomes;Urologic Oncology: Seminars and Original Investigations;2024-10

3. Differential NEUROD1, ASCL1, and POU2F3 Expression Defines Molecular Subsets of Bladder Small Cell/Neuroendocrine Carcinoma With Prognostic Implications;Modern Pathology;2024-10

4. A Single Institution Experience in the Management of Localized Neuroendocrine Carcinoma of the Bladder;Clinical Genitourinary Cancer;2024-09

5. Pathology focused review of morphologic subtypes and molecular variants of urothelial carcinoma with an emphasis on clinical/treatment relevance;Urologic Oncology: Seminars and Original Investigations;2024-07